ncRNA name
hsa-miR-20a
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
BNIP2
Cancer name
Colorectal Adenocarcinoma
Cancer site
Colon, Rectum, and Anus
Treatment type
Chemotherapy
Drug
Fluorouracil/Oxaliplatin/Teniposide
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MiR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines.
Tissue resource
colorectal cancer cell lines SW620
colorectal cancer cell lines SW480
Experiment
qRT-PCR,Western blot
Institute
Country
Continent